维普期刊资源整合服务平台（V6.5）

20篇 您的检索式：作者名="Filieri M"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

	题名	作者	年代	出处	被引量
1	Cabergoliue reduces cell viability in non functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 显示文摘	Gagliano T Filieri C Minoia M	2013	Pituitary2013，16，：	1
2	Influence of deslorat- adine on oxidative stress markers in patients with chronic idiopathic urticaria显示文摘	Cassano N Raho G Filieri M	2006	Int Dermatol2006，45，4：	1
3	Fexofenadine in chronic idiopat hic urticaria:a clinical and immunohistochemical evaluation显示文摘	Vena GA Cassano N Filieri M	2002	Int J Immunopathol Pharmacol2002，15，：	1
4	Fexofenadine in chronic idiopathic urticaria:a clinical and immunohistochemical evaluation 显示文摘	Vena GA Gassano N Filieri M	2002	Int J Immunopathol Pharmac ol2002，15，：	1
5	Structural so- cial capital evolution and knowledge transfer: Evidence from an Irish pharmaceutical network显示文摘	Filieri R Mcnally R O ' Dwyer M	2014	Industrial Marketing Management2014，43，3：	1
6	Fexofenadine in chronic idiopathic urticaria:a clinical and immunohistochemical evaluation 显示文摘	Vena GA Cassano N Filieri M	2002	Int J Immunopathol Pharmacol2002，15，3：	1
7	Fexofenadine in chronic idiopathic urticaria:a clinical and immunohistochemical evaluation显示文摘	Vena GA Cassano N Filieri M	2002	Int J Immunopathol Pharmacol2002，15，：	1
8	Effect of everolimus on cell viability in nonfunctioning pituitary adenomas显示文摘	Zatelli MC Minoia M Filieri C	2010	J Clin Endocrinol Metab2010，95，：	1
9	Effect of everolimus on cell viability in nonfunetioning pituitary adenomas 显示文摘	Zatelli MC Minoia M Filieri C	2010	J Clin Endocrinol Metab2010，95，2：	1
10	Fexofenadine in chronic idiopathic urticaria:a clinical and immunohistochemical evaluation显示文摘	Vena GA Cassano N Filieri M	2002	Int J Immunopathol Pharmacol2002，15，3：	1
11	Fexofenadine in chronic idiopathic urticaria:a clinical and immunohistochemical evaluation显示文摘	Vena GA Gassano N Filieri M	2002	Int J Immunopathol Pharmacol2002，，15：	1
12	Cabergoline reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 显示文摘	Gagliano T Filieri C Minoia M	2012	Pituitary2012，21，2：	1
13	Influence of desloratadine on oxidative stress markers in patients with chronic idiopathic urticaria显示文摘	Cassano N Raho G Filieri M	2006	Int Dermatol2006，45，4：	1
14	Fexofenadine in chronic idiopathic urticaria : a clinical and immunohistochemical evaluation 显示文摘	Vena GA Cassano N Filieri M	2002	Int J Immunopathol Pharmacol2002，15，3：	1
15	Fexofenadine in chronic idiopathic urticaria:a clinical and immunohistochemical evaluation显示文摘	Vena GA Cassano N Filieri M	2002	Int J Immunopathol Pharmacol2002，15，：	1
16	Fexofenadine in chronic idiopathic urticaria:a clinical and immunohistochemical evaluation显示文摘	VENA GA CASSANO N FILIERI M		0，，03：	1
17	Fexofenadine in chronic idiopathic urticaria:a clinical and immunohistochemical evaluation显示文摘	Vena GA Cassano N Filieri M		0，，03：	1
18	Influence of deslorata dine on oxidative stress markers in patients with chronic idio pathic urticaria显示文摘	Cassano N Raho G Filieri M	2006	Int J Dermatol2006，45，4：	1
19	Effect of everolimus on cell viability in nonfunctioning pituitary adenomas显示文摘	Zatelli MC Minoia M Filieri C		0，，02：	1
20	Influence of desloratadine on oxidative stress markers in patients with chronic idiopathic urticaria显示文摘	Cassano N Raho G Filieri M	2006	Int J Dermatol2006，45，4：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示